Featured Research

from universities, journals, and other organizations

Lavender And Tea Tree Oils May Cause Breast Growth In Boys

Date:
February 1, 2007
Source:
NIH/National Institute of Environmental Health Sciences
Summary:
A study published in this week's issue of the New England Journal of Medicine suggests that repeated topical use of products containing lavender oil and/or tea tree oil may cause prepubertal gynecomastia, a rare condition resulting in enlarged breast tissue in boys prior to puberty, and for which a cause is seldom identified.

A study published in this week's issue of the New England Journal of Medicine suggests that repeated topical use of products containing lavender oil and/or tea tree oil may cause prepubertal gynecomastia, a rare condition resulting in enlarged breast tissue in boys prior to puberty, and for which a cause is seldom identified.

Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), confirmed in laboratory studies what a pediatric endocrinologist at the University of Colorado at Denver and Health Science Center's School of Medicine suspected after diagnosing three of his young male patients with prepubertal gynecomastia. The researchers found an association between the use of products containing these oils and the rare disorder, but cautioned more research is needed. At this point, the findings are only applicable to young males with unexplainable enlarged breasts who are regularly using products containing these essential oils.

"We want to encourage doctors who may be seeing patients with gynecomastia to ask their patients about the products they are using. Patients with prepubertal gynecomastia may want to consider reducing the use of products that contain these oils," said Ken Korach, Ph.D., chief, Laboratory Reproductive and Developmental Toxicology at NIEHS and author on the study. "Although we found an association between exposure to these essential oils and gynecomastia, further research is needed to determine the prevalence of prepubertal gynecomastia in boys using products containing lavender and tea tree oils. Results of such epidemiological studies are important to tell us how strong the association is between topical application of the oils and prepubertal gynecomastia"

The three otherwise healthy Caucasian boys, ages four, seven and 10 years, had normal hormonal levels when they were diagnosed with gynecomastia by Clifford Bloch, M.D., in Colorado. All had either used lavender-scented soap and skin lotions, or shampoos or styling products that contained tea tree oil and lavender oil as ingredients. In each case, several months after the suspected products were discontinued, the gynecomastia had subsided or resolved.

After Bloch discussed the cases with Korach, the NIEHS researchers conducted experiments using human cells to determine if the oils mimic the effects of estrogen, the female hormone that stimulates breast tissue growth, or inhibited the effects of androgen, the hormone known to control masculine characteristics and inhibit the growth of breast tissue. The researchers tested the ability of the oils to modulate or inhibit gene expression.

"The results of our laboratory studies confirm that pure lavender and tea tree oils can mimic the actions of estrogens and inhibit the effects of androgens," said Korach. "This combinatorial activity makes them somewhat unique as endocrine disruptors."

Bloch said the laboratory studies support his hypothesis. "Since there was no identifiable cause for prepubertal gynecomastia in the three patients we reported, we speculated that environmental factors might be contributing to their condition. Together, the case histories and NIEHS in vitro studies provide support for our hypothesis that topical exposure to lavender and tea tree oils likely caused gynecomastia in the three patients."

The oils did not alter the levels of the usual forms of circulating estrogens and androgens in the boys. "We do not anticipate any long term effects on hormonal levels," said Derek Henley, Ph.D., the lead NIEHS author on the study. It is unknown whether the oils have similar endocrine disrupting effects in prepubertal girls, adolescents or adults.

"This study clearly demonstrates how clinical observations can be supported by basic science research," said NIEHS Director David A. Schwartz, M.D.

These essential oils might now be considered endocrine disruptors since they appeared to have caused an imbalance in estrogen and androgen signaling. Endocrine disruptors are naturally occurring compounds or synthetic chemicals that may interfere with the production or activity of hormones of the endocrine system leading to adverse health effects.

The National Institute of Environmental Health Sciences (NIEHS), a component of the National Institutes of Health, supports research to understand the effects of the environment on human health. For more information on environmental health topics, please visit our website at http://www.niehs.nih.gov/.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Reference: Henley D, Lipson N, Korach K, Bloch C. Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils. New England Journal of Medicine, Feb. 1, 2007.


Story Source:

The above story is based on materials provided by NIH/National Institute of Environmental Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute of Environmental Health Sciences. "Lavender And Tea Tree Oils May Cause Breast Growth In Boys." ScienceDaily. ScienceDaily, 1 February 2007. <www.sciencedaily.com/releases/2007/01/070131204136.htm>.
NIH/National Institute of Environmental Health Sciences. (2007, February 1). Lavender And Tea Tree Oils May Cause Breast Growth In Boys. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/01/070131204136.htm
NIH/National Institute of Environmental Health Sciences. "Lavender And Tea Tree Oils May Cause Breast Growth In Boys." ScienceDaily. www.sciencedaily.com/releases/2007/01/070131204136.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins